SCM
ARNA

Silverarc Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Silverarc Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-18,581
Closed -$1.11M – 94
2021
Q3 		$1.11M Sell
18,581
-1,996
-10% -$118K 0.63% 50
2021
Q2 		$1.4K Buy
20,577
+577
+3% +$37.6K 0.63% 57
2021
Q1 		$1.39M Hold
20,000
– – 0.76% 49
2020
Q4 		$1.54M Buy
+20,000
New +$1.5M 0.89% 39

Other funds holding ARNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Silverarc Capital Management's ARNA Position: Q4 2021 in Review

Silverarc Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 18,581 shares — an estimated $1.11M sold.

Silverarc Capital Management first reported a position in ARNA in Q4 2020 and held it in 4 quarters. The position peaked at $1.54M in Q4 2020. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • Silverarc Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • Silverarc Capital Management sold 18,581 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $1.11M.
  • Silverarc Capital Management first reported a position in Arena Pharmaceuticals Inc in Q4 2020 and held it in 4 quarters.
  • Silverarc Capital Management's Arena Pharmaceuticals Inc position peaked at $1.54M in Q4 2020.
  • 316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Silverarc Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.